Skip to content

Clinical trials

Phase 3 Dwarfism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dwarfism Phase: Phase 3 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20101
20131
20161
20171
20182
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical3
Changchun GeneScience Pharmaceutical Co., Ltd.2
Ipsen2
Ascendis Pharma A/S1
Dong-A ST Co., Ltd.1
Eli Lilly and Company1
Nationwide Children's Hospital1
QED Therapeutics, a BridgeBio company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dwarfism12
Bone Diseases4
Genetic Diseases, Inborn4
Musculoskeletal Diseases4
Osteochondrodysplasias4
Turner Syndrome4
Achondroplasia3
Bone Diseases, Developmental3
Failure to Thrive2
Chromosome Disorders1

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.